Skip to main content

and
  1. Article

    Open Access

    Vaccination against COVID-19 — risks and benefits in children

    Countries in Europe and around the world have taken varying approaches to their policies on COVID-19 vaccination for children. The low risk of severe illness from COVID-19 means that even small risks from vacc...

    Alasdair P. S. Munro, Christine E. Jones, Saul N. Faust in European Journal of Pediatrics (2024)

  2. Article

    Open Access

    Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomi...

    Peter W. Horby, Leon Peto, Natalie Staplin, Mark Campbell in Nature Communications (2024)

  3. Article

    Open Access

    Parental concern for clinically vulnerable child during first 18 months of the COVID pandemic

    The uncertainties surrounding the COVID-19 pandemic have been associated with increased parental concern. The aim of this study is to explore if this increased level of concern is associated with certain indiv...

    Corine Driessens, Lynne Mills, David Culliford, Ravin Patel, Emma Lee in Pediatric Research (2023)

  4. Article

    Open Access

    Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves

    We hypothesised that the clinical characteristics of hospitalised children and young people (CYP) with SARS-CoV-2 in the UK second wave (W2) would differ from the first wave (W1) due to the alpha variant (B.1....

    Olivia V. Swann, Louisa Pollock, Karl A. Holden, Alasdair P. S. Munro in Pediatric Research (2023)

  5. Article

    Open Access

    Changes in serotype prevalence of Streptococcus pneumoniae in Southampton, UK between 2006 and 2018

    Streptococcus pneumoniae continues to cause significant disease burden. Whilst pneumococcal conjugate vaccines (PCV) have substantially reduced this burden, serotype replacement partially negates this success due...

    David W. Cleary, Jessica Jones, Rebecca A. Gladstone, Karen L. Osman in Scientific Reports (2022)

  6. Article

    Open Access

    Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study

    Patients with hematological malignancies are at increased risk of severe COVID-19 outcomes due to compromised immune responses, but the insights of these studies have been compromised due to intrinsic limitati...

    Sean H. Lim, Beth Stuart, Debora Joseph-Pietras, Marina Johnson in Nature Cancer (2022)

  7. Article

    Open Access

    RSV: perspectives to strengthen the need for protection in all infants

    Respiratory syncytial virus (RSV)—the most common viral cause of bronchiolitis—is a significant cause of serious illness among young children between the ages of 0–5 years and is especially concerning in the f...

    Jose Antonio Navarro Alonso, Louis J. Bont in Emerging Themes in Epidemiology (2021)

  8. Article

    Open Access

    Paediatric research in the times of COVID-19

    The COVID-19 pandemic poses many direct and indirect consequences for children’s health and associated research. Direct consequences include participation of children in COVID-19 research trials, pausing other...

    Paul F. Fleming, Chris Gale, Eleanor J. Molloy, Saul N. Faust in Pediatric Research (2021)

  9. Article

    Open Access

    Experts’ opinion for improving global adolescent vaccination rates: a call to action

    Worldwide, lifestyle and resource disparities among adolescents contribute to unmet health needs, which have crucial present and future public health implications for both adolescents and broader communities. ...

    Chiara Azzari, Javier Diez-Domingo, Evelyn Eisenstein in European Journal of Pediatrics (2020)

  10. Article

    Executive summary: surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children

    Scott L. Weiss, Mark J. Peters, Waleed Alhazzani in Intensive Care Medicine (2020)

  11. Article

    Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children

    To develop evidence-based recommendations for clinicians caring for children (including infants, school-aged children, and adolescents) with septic shock and other sepsis-associated organ dysfunction.

    Scott L. Weiss, Mark J. Peters, Waleed Alhazzani in Intensive Care Medicine (2020)

  12. Article

    Open Access

    Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-blind, randomized study

    A new formulation of the live-attenuated varicella vaccine Varilrix (GSK) produced without human serum albumin (HSA) was developed to minimize a theoretical risk of transmission of infectious diseases. A previous...

    Saul N. Faust, Maguelone Le Roy, Chitsanu Pancharoen in BMC Pediatrics (2019)

  13. Article

    Open Access

    Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP

    We assessed a combination multi-stage malaria vaccine schedule in which RTS,S/AS01B was given concomitantly with viral vectors expressing multiple-epitope thrombospondin-related adhesion protein (ME-TRAP) in a...

    Tommy Rampling, Katie J. Ewer, Georgina Bowyer, Nick J. Edwards in npj Vaccines (2018)

  14. Article

    Open Access

    Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP

    Heterologous prime-boost vaccination with viral vectors simian adenovirus 63 (ChAd63) and Modified Vaccinia Ankara (MVA) induces potent T cell and antibody responses in humans. The 8-week regimen demonstrates ...

    Carly M. Bliss, Georgina Bowyer, Nicholas A. Anagnostou, Tom Havelock in Scientific Reports (2018)

  15. Article

    Open Access

    Pneumococcal conjugate vaccine implementation in middle-income countries

    Since 2000, the widespread adoption of pneumococcal conjugate vaccines (PCVs) has had a major impact in the prevention of pneumonia. Limited access to international financial support means some middle-income c...

    Serena Tricarico, Hannah C. McNeil, David W. Cleary, Michael G. Head in Pneumonia (2017)

  16. No Access

    Chapter

    Clostridium difficile in Children: A Review of Existing and Recently Uncovered Evidence

    The clinical significance of the presence of Clostridium difficile in children’s faeces remains uncertain using current diagnostic procedures. Clostridium difficile is a relatively common finding in infants with ...

    Oliver Morris, Marc Tebruegge, Ann Pallett in Hot Topics in Infection and Immunity in Ch… (2013)

  17. No Access

    Chapter

    Purpura Fulminans

  18. Purpura fulminans has many causes, both infectious and non-infectious.

  19. It is a common clinical and histologic...

  20. Saul N. Faust, Simon Nadel in Life-Threatening Dermatoses and Emergencies in Dermatology (2009)

  21. No Access

    Article

    Platelet and soluble CD40L in meningococcal sepsis

    To determine the influence of meningococcal sepsis on levels of platelet derived CD40L and on endothelial CD40 expression.

    David P. Inwald, Saul N. Faust, Paula Lister, Mark J. Peters in Intensive Care Medicine (2006)

  22. No Access

    Chapter and Conference Paper

    HIV-1 Infection in Children: Current Practice and Future Predictions

    This review will discuss the global epidemiology and clinical classification of HIV-1 in children, and the management and treatment principles in an industrialized economic setting. The epidemiology highlights...

    Lauri-Ann Van der Poel, Saul N. Faust in Hot Topics in Infection and Immunity in Ch… (2004)